Financials
- Market Capitalization 204.15 M
- Employee 117
- Founded 1999
- CEO N/A
- Website www.niagenbioscience.com
- Headquarter Delaware, United States
- FIGI BBG000BG1J71
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
31.8
Relación precio/flujo de caja
4.2
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3502 | SION Sionna Therapeutics, Inc. - Common Stock | 4.55 USD | -2.99% | -2.78% | -41.96% | -88.43% | 205.72 M USD | ||
| 3505 | RNAC Cartesian Therapeutics, Inc. - Common Stock | 6.83 USD | -2.29% | -4.21% | -16.61% | -25.44% | 206.64 M USD | ||
| 3529 | LYEL Lyell Immunopharma, Inc. - Common Stock | 8.02 USD | -3.02% | -10.69% | -33.00% | -66.85% | 196.53 M USD | ||
| 3534 | SLGL Sol-Gel Technologies Ltd. - Ordinary Shares | 72.43 USD | +0.04% | -7.16% | +9.38% | +90.61% | 201.80 M USD |